| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,807 |
16,949 |
$1.21M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,715 |
4,168 |
$385K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,003 |
2,904 |
$227K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,060 |
1,896 |
$143K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,849 |
1,798 |
$139K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,323 |
3,114 |
$87K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,396 |
2,174 |
$77K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,713 |
5,269 |
$73K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
449 |
422 |
$72K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,302 |
2,157 |
$67K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
576 |
560 |
$47K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,878 |
4,647 |
$39K |
| 90670 |
|
1,328 |
1,269 |
$34K |
| 92551 |
|
3,569 |
3,430 |
$33K |
| 99058 |
|
1,245 |
1,040 |
$30K |
| 90671 |
|
169 |
164 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
308 |
299 |
$25K |
| 90680 |
|
1,303 |
1,227 |
$22K |
| 92552 |
|
656 |
641 |
$19K |
| 90698 |
|
1,045 |
974 |
$19K |
| 90633 |
|
1,250 |
1,189 |
$16K |
| 99215 |
Prolong outpt/office vis |
126 |
113 |
$13K |
| 90677 |
|
250 |
237 |
$10K |
| 90649 |
|
162 |
151 |
$10K |
| 90658 |
|
948 |
883 |
$9K |
| 99173 |
|
3,199 |
3,064 |
$7K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,723 |
6,285 |
$7K |
| 90744 |
|
617 |
560 |
$7K |
| 90648 |
|
607 |
583 |
$6K |
| 93000 |
|
479 |
444 |
$6K |
| 99177 |
|
1,556 |
1,532 |
$6K |
| 96127 |
|
1,151 |
1,139 |
$6K |
| 90461 |
|
3,638 |
3,418 |
$6K |
| 90716 |
|
248 |
241 |
$5K |
| 99381 |
|
81 |
68 |
$5K |
| 90710 |
|
163 |
163 |
$5K |
| 90700 |
|
344 |
329 |
$4K |
| 90707 |
|
245 |
240 |
$4K |
| 90696 |
|
200 |
198 |
$3K |
| 90723 |
|
212 |
206 |
$3K |
| 90686 |
|
158 |
156 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
262 |
233 |
$2K |
| 87807 |
|
151 |
135 |
$2K |
| 94664 |
|
137 |
119 |
$2K |
| 90674 |
|
82 |
82 |
$2K |
| 90655 |
|
146 |
121 |
$1K |
| 90651 |
|
36 |
36 |
$1K |
| 0001A |
|
38 |
38 |
$1K |
| 0002A |
|
35 |
35 |
$1K |
| 99442 |
|
15 |
15 |
$995.64 |
| 90734 |
|
26 |
26 |
$938.50 |
| 99402 |
|
21 |
17 |
$682.08 |
| 99000 |
|
2,451 |
2,197 |
$301.76 |
| 86580 |
|
37 |
37 |
$270.60 |
| 90715 |
|
15 |
15 |
$185.66 |
| A4617 |
Mouth piece |
139 |
122 |
$137.27 |
| A7015 |
Aerosol mask, used with dme nebulizer |
258 |
232 |
$133.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41 |
38 |
$64.60 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
139 |
121 |
$56.61 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
158 |
137 |
$25.56 |
| 99072 |
|
43 |
43 |
$15.00 |
| 91300 |
|
112 |
109 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
17 |
15 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
12 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
12 |
12 |
$0.00 |